Every ingredient claim we score, graded A–F on the strength of the peer-reviewed research behind it. Search, filter and jump to the studies.
| Compare | Claim | Grade |
|---|---|---|
| Lower oxidation risk than large-fish oil Short-lived species carry less heavy-metal load and typically fresher on shelf. View studies & products → | ASave |
| Compare | Claim | Grade |
|---|---|---|
| Reduces OA signs in dogs Old open-label canine study showed benefit; better human evidence in OA. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Reduces recurrent bacterial UTI risk Some evidence via anti-adhesion; not a treatment for active UTI. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Neurologic and retinal development in puppies Diets enriched with DHA improve trainability and visual acuity in puppies. View studies & products → | ASave |
Randomized canine trials support EPA and DHA for osteoarthritis. Credit depends on the actual disclosed EPA+DHA dose, not merely total oil weight.
| Compare | Claim | Grade |
|---|---|---|
| Reduces clinical signs of osteoarthritis in dogs Multiple randomised controlled trials show improved weight bearing, owner-assessed lameness and ability to rise at ~50–100 mg EPA+DHA / kg / day. View studies & products → | ASave | |
| Improves skin/coat and reduces pruritus in atopic dogs Consistent modest benefit as adjunctive therapy; effect size smaller than for OA. View studies & products → | BSave | |
| Slows cognitive decline in senior dogs Small canine studies suggestive; strongest evidence is from broader nutrient blends. View studies & products → | CSave |
Canine veterinary references and clinical literature support pancreatic enzyme replacement for exocrine pancreatic insufficiency. Evidence does not establish a general health benefit for dogs without pancreatic enzyme deficiency.
Human and preclinical evidence exists; direct canine clinical efficacy has not been established.
| Compare | Claim | Grade |
|---|---|---|
| Comparable OA benefit to fish oil per mg EPA+DHA Small trials show similar outcomes; higher cost per mg omega-3 in Canada. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Essential for bone, immune and cardiac health Deficiency and excess both harmful; supplement only when a diet is measured-deficient. View studies & products → | ASave |
| Compare | Claim | Grade |
|---|---|---|
| Anti-inflammatory / odour-reduction claims Mostly in-vitro and anecdotal; safety concerns at high doses. View studies & products → | DSave |
| Compare | Claim | Grade |
|---|---|---|
| Adds modest benefit when combined with glucosamine Best evidence is combined formulations; monotherapy data are weaker. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Anti-inflammatory joint benefit in dogs Active omega-3 responsible for most of the OA effect; dose reported per EPA content. View studies & products → | ASave |
Canine feeding studies show absorption of flaxseed ALA and some conversion to EPA/DPA, but not reliable conversion to DHA or demonstrated joint-pain benefit.
| Compare | Claim | Grade |
|---|---|---|
| Reduces mild-to-moderate OA signs in dogs Meta-analyses show a small but real benefit; effect is smaller than NSAIDs and slower to onset. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Reduces OA pain and joint swelling Several canine trials support use at ~30 mg/kg/day of stabilised powder. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| General gut and immune support Effects depend on strain identity, CFU at expiry, and delivery survival. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Reduces dental plaque and calculus in dogs Multiple RCTs on the ProDen PlaqueOff strain show plaque/tartar reduction. View studies & products → | BSave |
Canine research supports dietary fibre supplementation for gastrointestinal function, and pumpkin is a recognised mixed soluble/insoluble fibre source discussed in veterinary nutrition. There are no controlled clinical trials of this specific commercial dehydrated pumpkin product, so evidence is graded on the ingredient class and mechanism rather than product-level trials.
| Compare | Claim | Grade |
|---|---|---|
| Reduces acute and antibiotic-associated diarrhoea in dogs Randomised canine data support use for AAD and stress diarrhoea. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Same benefits as fish oil at label EPA/DHA dose Bioequivalent when EPA+DHA dose is matched; sourcing and freshness matter more than species. View studies & products → | ASave |
| Compare | Claim | Grade |
|---|---|---|
| Hepatoprotective; helps in copper and steroid hepatopathy Multiple canine studies support use, often combined with silybin. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Improves lameness scores comparable to glucosamine+chondroitin Small canine RCTs (40 mg/day) show improvement in force-plate and owner scores. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Antioxidant support especially with high PUFA diets Requirement rises with fish/omega-3 intake. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Reduces stress-associated diarrhoea (strain AHC7) Strain-specific canine RCTs support this; not all Bifido products are equivalent. View studies & products → | BSave |
| Compare | Claim | Grade |
|---|---|---|
| Palatability, hydration and modest gelatin/amino acid content No strong disease-modifying evidence; safe when made without onion/garlic/excess salt. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Adjunct in canine cardiomyopathy Small canine data; often used empirically alongside standard cardiology treatment. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Modulates immune and gut markers Small studies; effect sizes modest and variable by source. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Meaningful benefit only in EPI-diagnosed dogs Otherwise limited benefit in normal dogs on complete diets. View studies & products → | CSave |
Canine evidence exists for undenatured type II collagen, but this fish collagen powder is not confirmed to match that studied form.
| Compare | Claim | Grade |
|---|---|---|
| Palatability and moisture-free convenience Nutritional benefit depends on the base diet; pathogen risk exists in raw formats. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Palatability and probiotic delivery (if raw/fermented) Modest evidence for tolerance vs cow milk; not a meaningful nutrient source. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Reduces situational anxiety in dogs Open-label and small blinded studies suggest benefit for storm/travel anxiety. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Improves stool quality in healthy dogs Strain-specific; general genus claims are weak. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Cognitive and nerve-growth-factor support Rodent and human pilot data; no controlled canine trials yet. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Aids sleep and reduces noise-phobia signs Mostly clinical experience and small case series; behavioural plan should be first-line. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Hepatoprotective adjunct for liver disease Silybin-phosphatidylcholine complexes have the best pharmacokinetic data in dogs. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Adjunctive OA pain relief Mostly extrapolated from human OA trials; limited dog-specific RCTs. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Improves faecal microbiome diversity Short-chain FOS/inulin evidence is largely surrogate-marker based. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| General immune modulation Mostly in-vitro and rodent data; canine outcome data limited. View studies & products → | CSave |
| Compare | Claim | Grade |
|---|---|---|
| Extended survival in canine hemangiosarcoma (small study) Single small trial (Brown 2012, PSK 100 mg/kg); results have not been replicated at scale. View studies & products → | CSave |
Limited canine combination-product evidence exists; unstandardized turmeric root powder is not equivalent to a quantified curcuminoid extract.
| Compare | Claim | Grade |
|---|---|---|
| Adjunctive anti-inflammatory effect in canine OA Bioavailability is the main limit; results are mixed and formulation-dependent. View studies & products → | CSave |
No reliable canine clinical evidence supports Aconite 200C for fear, shock, pain, inflammation or injury.
Systematic review evidence does not support homeopathic Arnica as more effective than placebo.
| Compare | Claim | Grade |
|---|---|---|
| Source of iodine and trace minerals Iodine content is highly variable batch-to-batch; risk of over-supplementation. View studies & products → | DSave |
Educational information only. Not veterinary advice. Always talk to your vet before starting a new supplement.